Concepedia

Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma

Xin Li, Jiahua Xu, Xiaoqiang Gu, Ling Chen, Qing Wu, Hongwei Li, Haoran Bai, Jinzu Yang, Jianxin Qian

Frontiers in Immunology · 2021 · 12 citations · 12 references

DOIFull text

Open access

Abstract

Anti-angiogenic therapy and immune checkpoint inhibitors combined with cryoablation can induce a powerful and effective systemic anti-tumor immune response, which is worthy of further research.

References

12

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 109.5K citations · Full text

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 6.8K citations · Full text

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

Yuhui Huang, Jian‐Ping Yuan, Elda Righi et al. · Proceedings of the National Academy of Sciences · 2012 · 1K citations · Full text

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott et al. · Journal of the National Comprehensive Cancer Network · 2021 · 999 citations · Full text

, , +22

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma

Zhen Zeng, Feng Shi, Lin Zhou et al. · PLoS ONE · 2011 · 166 citations · Full text